vs

Side-by-side financial comparison of GREENE COUNTY BANCORP INC (GCBC) and Zymeworks Inc. (ZYME). Click either name above to swap in a different company.

Zymeworks Inc. is the larger business by last-quarter revenue ($27.6M vs $22.2M, roughly 1.2× GREENE COUNTY BANCORP INC). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -71.0%, a 117.3% gap on every dollar of revenue. On growth, Zymeworks Inc. posted the faster year-over-year revenue change (72.6% vs 23.8%). GREENE COUNTY BANCORP INC produced more free cash flow last quarter ($6.2M vs $-31.8M).

Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.

Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital th...

GCBC vs ZYME — Head-to-Head

Bigger by revenue
ZYME
ZYME
1.2× larger
ZYME
$27.6M
$22.2M
GCBC
Growing faster (revenue YoY)
ZYME
ZYME
+48.8% gap
ZYME
72.6%
23.8%
GCBC
Higher net margin
GCBC
GCBC
117.3% more per $
GCBC
46.3%
-71.0%
ZYME
More free cash flow
GCBC
GCBC
$38.0M more FCF
GCBC
$6.2M
$-31.8M
ZYME

Income Statement — Q2 FY2026 vs Q3 FY2025

Metric
GCBC
GCBC
ZYME
ZYME
Revenue
$22.2M
$27.6M
Net Profit
$10.3M
$-19.6M
Gross Margin
Operating Margin
52.0%
-80.1%
Net Margin
46.3%
-71.0%
Revenue YoY
23.8%
72.6%
Net Profit YoY
37.4%
34.3%
EPS (diluted)
$0.60
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GCBC
GCBC
ZYME
ZYME
Q4 25
$22.2M
Q3 25
$21.5M
$27.6M
Q2 25
$20.5M
$48.7M
Q1 25
$20.1M
$27.1M
Q4 24
$17.9M
$31.0M
Q3 24
$16.9M
$16.0M
Q2 24
$16.6M
$19.2M
Q1 24
$15.7M
$10.0M
Net Profit
GCBC
GCBC
ZYME
ZYME
Q4 25
$10.3M
Q3 25
$8.9M
$-19.6M
Q2 25
$9.3M
$2.3M
Q1 25
$8.1M
$-22.6M
Q4 24
$7.5M
$-23.5M
Q3 24
$6.3M
$-29.9M
Q2 24
$6.7M
$-37.7M
Q1 24
$5.9M
$-31.7M
Operating Margin
GCBC
GCBC
ZYME
ZYME
Q4 25
52.0%
Q3 25
47.4%
-80.1%
Q2 25
53.5%
-1.4%
Q1 25
44.6%
-94.5%
Q4 24
45.0%
-71.6%
Q3 24
39.6%
-213.8%
Q2 24
41.2%
-222.9%
Q1 24
39.4%
-376.9%
Net Margin
GCBC
GCBC
ZYME
ZYME
Q4 25
46.3%
Q3 25
41.2%
-71.0%
Q2 25
45.6%
4.8%
Q1 25
40.1%
-83.5%
Q4 24
41.7%
-75.8%
Q3 24
37.1%
-186.6%
Q2 24
40.6%
-195.8%
Q1 24
37.3%
-315.6%
EPS (diluted)
GCBC
GCBC
ZYME
ZYME
Q4 25
$0.60
Q3 25
$0.52
$-0.26
Q2 25
$0.55
$0.03
Q1 25
$0.47
$-0.30
Q4 24
$0.44
$-0.32
Q3 24
$0.37
$-0.39
Q2 24
$0.39
$-0.49
Q1 24
$0.34
$-0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GCBC
GCBC
ZYME
ZYME
Cash + ST InvestmentsLiquidity on hand
$64.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$258.3M
$320.1M
Total Assets
$3.1B
$397.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GCBC
GCBC
ZYME
ZYME
Q4 25
Q3 25
$64.8M
Q2 25
$98.3M
Q1 25
$155.5M
$76.2M
Q4 24
$166.4M
$66.1M
Q3 24
$122.4M
Q2 24
$190.4M
$71.0M
Q1 24
$114.8M
Stockholders' Equity
GCBC
GCBC
ZYME
ZYME
Q4 25
$258.3M
Q3 25
$248.2M
$320.1M
Q2 25
$238.8M
$334.5M
Q1 25
$229.0M
$325.0M
Q4 24
$218.4M
$338.8M
Q3 24
$216.3M
$367.0M
Q2 24
$206.0M
$406.2M
Q1 24
$199.2M
$438.0M
Total Assets
GCBC
GCBC
ZYME
ZYME
Q4 25
$3.1B
Q3 25
$3.1B
$397.3M
Q2 25
$3.0B
$408.4M
Q1 25
$3.0B
$425.5M
Q4 24
$3.0B
$463.1M
Q3 24
$2.9B
$487.2M
Q2 24
$2.8B
$515.6M
Q1 24
$2.9B
$553.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GCBC
GCBC
ZYME
ZYME
Operating Cash FlowLast quarter
$6.4M
$-31.4M
Free Cash FlowOCF − Capex
$6.2M
$-31.8M
FCF MarginFCF / Revenue
28.0%
-115.2%
Capex IntensityCapex / Revenue
0.9%
1.5%
Cash ConversionOCF / Net Profit
0.62×
TTM Free Cash FlowTrailing 4 quarters
$47.3M
$-65.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GCBC
GCBC
ZYME
ZYME
Q4 25
$6.4M
Q3 25
$7.0M
$-31.4M
Q2 25
$28.0M
$12.1M
Q1 25
$7.3M
$-3.4M
Q4 24
$5.3M
$-41.5M
Q3 24
$2.1M
$-5.9M
Q2 24
$24.9M
$-25.0M
Q1 24
$5.6M
$-37.7M
Free Cash Flow
GCBC
GCBC
ZYME
ZYME
Q4 25
$6.2M
Q3 25
$6.5M
$-31.8M
Q2 25
$27.3M
$11.6M
Q1 25
$7.3M
$-3.4M
Q4 24
$5.1M
$-41.8M
Q3 24
$2.0M
$-6.8M
Q2 24
$23.4M
$-25.6M
Q1 24
$4.9M
$-37.9M
FCF Margin
GCBC
GCBC
ZYME
ZYME
Q4 25
28.0%
Q3 25
30.4%
-115.2%
Q2 25
133.3%
23.7%
Q1 25
36.1%
-12.6%
Q4 24
28.6%
-134.8%
Q3 24
11.8%
-42.4%
Q2 24
141.2%
-133.0%
Q1 24
31.3%
-377.5%
Capex Intensity
GCBC
GCBC
ZYME
ZYME
Q4 25
0.9%
Q3 25
1.9%
1.5%
Q2 25
3.4%
1.1%
Q1 25
0.3%
0.1%
Q4 24
1.0%
1.0%
Q3 24
0.9%
5.6%
Q2 24
9.1%
3.1%
Q1 24
4.2%
1.8%
Cash Conversion
GCBC
GCBC
ZYME
ZYME
Q4 25
0.62×
Q3 25
0.78×
Q2 25
3.00×
5.21×
Q1 25
0.91×
Q4 24
0.71×
Q3 24
0.34×
Q2 24
3.70×
Q1 24
0.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons